Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026)

Adaptive Biotechnologies (ADPT) posted Restructuring Costs of $643000.0 for Q1 2026, up 639.08% sequentially from $87000.0 in Q4 2024.

Adaptive Biotechnologies (ADPT) Restructuring Costs (2024 - 2026) Analysis & Trends

Adaptive Biotechnologies (ADPT) has 2 years of Restructuring Costs data on file, last reported at $643000.0 in Q1 2026.

Quarterly Restructuring Costs changed N/A year-over-year to $643000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $923000.0 (down 3.85% YoY) and the FY2024 annual result came in at $2.0 million, changed N/A from the prior year.
Restructuring Costs rose to $643000.0 in Q1 2026 per ADPT's latest filing, from $87000.0 in the prior quarter.
The five-year high for Restructuring Costs was $1.0 million in Q1 2024, with the low at $87000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Adaptive Biotechnologies	3.48 Bn	3.27 Bn	52.17 Mn

Download Data